ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
67 090,02
0,01%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. USOTC
  6. Algorae Pharmaceuticals Limited (QB) (LVCLY)

  7. Algorae Pharmaceuticals Limited (QB) (LVCLY) Actualités

LVCLY

Algorae Pharmaceuticals (QB) (LVCLY)

Algorae Pharmaceuticals Limited (QB)
De:
Trier par:
 Showing the most relevant articles for your search:USOTC:LVCLY
DateHeureSourceTitreSymboleSociété
15/10/201305h40OTC MarketsAnnual ReportUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
15/10/201305h37OTC MarketsNotice of Annual General Meeting / Proxy FormUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
20/09/201302h50OTC MarketsFirst patient successfully implanted with NTCELLUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
16/09/201305h37OTC MarketsPublication of pre-clinical trial of NTCELL in Parkinson'sUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
30/08/201304h10OTC MarketsPreliminary ResultsUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
29/08/201305h51OTC MarketsLCT Announces Change in Regulatory StrategyUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
27/08/201304h19OTC MarketsPreliminary Internal Review of Dia-12 StudyUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
01/08/201303h23OTC MarketsChange of Director's Interest NoticeUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
31/07/201302h06OTC MarketsAppendix 4C Quarterly ReportUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
29/05/201303h21OTC MarketsChange of Directors' Interests NoticeUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
09/05/201306h37OTC MarketsOpen Briefing LCT Clinical Trials UpdateUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
29/04/201301h41OTC MarketsQuarterly ReportUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
20/03/201323h47OTC MarketsCEO on Strategy - Audio InterviewUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
20/03/201323h46OTC MarketsOpen Briefing - CEO on StrategyUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
19/03/201323h04OTC MarketsLCT Awarded NZBIO Company of the YearUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
27/02/201302h53OTC MarketsSemi-Annual ReportUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
27/02/201302h42OTC MarketsAnouncement on Half-Year ReportUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
17/12/201202h48OTC MarketsOpen Briefing interview with MD and CEO Andrea GrantUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
17/12/201202h47OTC MarketsLCT & Otsuka to co-develop NTCELL for Parkinson's DiseaseUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
09/12/201223h11OTC MarketsLCT appoints Chief Science and Medical OfficerUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
22/11/201201h02OTC MarketsLCT starts DIABECELL Phase IIb trial in ArgentinaUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
22/11/201201h00OTC MarketsStrong interim results in Argentinian DIABECELL trialUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
19/11/201206h28OTC MarketsInitial Directors Interest NoticeUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
16/11/201206h03OTC MarketsResults of the 2012 Annual General MeetingUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
16/11/201204h40OTC MarketsAGM PresentationUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
16/11/201204h38OTC MarketsChairman's Address to the 2012 Annual General MeetingUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
15/11/201223h48OTC MarketsLCT CEO Dr Andrea Grant appointed Managing DirectorUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
15/11/201223h40OTC MarketsEthical approval for LCT's NTCELL Phase I trialUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
04/11/201223h37OTC MarketsHome Country News ReleaseUSOTC:LVCLYAlgorae Pharmaceuticals Limited (QB)
 Showing the most relevant articles for your search:USOTC:LVCLY

Dernières Valeurs Consultées

LSE
CJ98
Sg Issuer 32
BIT
UC1C53
Unicredit Bank
LSE
BDYA
BIT
S27202
Societe Generale Effekten
TSX
HGD
BetaPro Canadian Gold Mi...
BOV
A1TM34Q
Atmos Energy
BIT
F29938
Vontobel Financial Produ...
DGFX
ALCAZARLEOUSDT
Alcazar
ASX
CBAKOP
BIT
F37014
Vontobel Financial Produ...
AQSE
MSI.GB
MS
BIT
S31873
Societe Generale Effekten
ASX
ASAO
Abrdn Australia
NYSE
LLY.43
Lilly (Eli) &
BOV
PASS3
Compass Gas E Energia ON
TSX
CINT
CIBC International Equit...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés